| | June 9, 2021 Dear International Colleague, In case you missed this yesterday, the White House, the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response and the U.S. Food and Drug Administration (FDA) released a series of policy recommendations to address the vulnerabilities in U.S. pharmaceutical supply chains. Led by HHS, the White House report and its recommendations have been accepted by President Biden. "Last year the American people experienced a widespread and significant shortage of N95 respirators for healthcare workers and masks to protect essential workers and others, and year after year we see shortages of medicines and medical supplies like saline," said FDA Acting Commissioner Janet Woodcock. "Pharmaceutical supply chains are essential for the national and health security and economic prosperity of the United States, yet the COVID-19 pandemic revealed just how vulnerable the supply chain is in this country. Now is the right time to take action to keep the U.S. drug supply chain secure and resilient." Related link: Biden Administration Recommends Policy Changes to Secure U.S. Pharmaceutical Supply Chain | | | |
No comments:
Post a Comment